secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002748
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics updates investor presentation focused on T1D pipeline; no specific new data disclosed
--------------------------------------------------------------------------------

- Filed updated slide presentation under Item 7.01 used in investor meetings, dated January 12, 2026.
- Presentation titled 'Unlocking the Value of our Pipeline for T1D' signals strategic focus on type 1 diabetes.
- Available text contains only cover slide and forward-looking statements; no new clinical or financial details visible.
- No changes to guidance, pipeline milestones, or financial outlook were provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926002748/0001104659-26-002748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926002748/tm262422d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer